(IBD)?
About GlycanTrigger project
GlycanTrigger is a project funded by the European Union within the Horizon Europe Research and Innovation Actions, bringing together 9 organisations from 6 different European countries and 1 non-European country (USA).
In GlycanTrigger, we will investigate when, why and how changes in gut glycome trigger health-to-chronic inflammation transition. The project started in January 2023 and will be developed for 6 years under the coordination of Instituto de Investigação e Inovação em Saúde (i3S) from the University of Porto, Portugal. The GlycanTrigger consortium includes representatives from medical universities and research centers, clinical centers, one biotechnology company, one consultancy company, and one European patients’ association.
Key Numbers
Budget
6.8 M€
Duration
72 months
9 partners
6 European countries
1 USA
Diseases
Crohn’s disease (CD)
Ulcerative Colitis (UC)
Highlights
News & Events
The GlycanTrigger Project is hiring a Postdoc Researcher to join Pinho’s Lab at i3S – Institute of Health Innovation and Research.
The GlycanTrigger Project is hiring a Postdoc Researcher to join Pinho’s Lab at i3S – Institute of Health Innovation and Research. The selected candidate will join a research [...]
Crohn’s & Colitis Awareness Week
December 1-7 marks Crohn’s & Colitis Awareness Week, shedding light on the challenges associated with Crohn’s disease and ulcerative colitis, both classified as Inflammatory Bowel Diseases (IBD). These [...]
